Search for a report

Reports

  • You are here:
  • Home
  • Downloads
  • GLOBAL CARTILAGE DEGENERATION MARKET FORECAST 2021-2028

GLOBAL CARTILAGE DEGENERATION MARKET FORECAST 2021-2028

The global cartilage degeneration market is anticipated to register a CAGR of 4.64% over the forecasted years and is expected to generate revenue of $11551.2 million by 2028. While the base year considered for the market study is 2020, the forecast period is from 2021 to 2028.

Cartilage is a smooth, connective tissue that cushions the meeting area of joints and bone. The degeneration of cartilage can cause chronic inflammation in the joints. Some of the risk factors for cartilage denegation include weight, aging, accidental injury, sports injuries, or trauma to joints such as knees or hips.

GLOBAL CARTILAGE DEGENERATION MARKET FORECAST 2021-2028

Global Cartilage Degeneration Market by Procedure (Joint Replacement, Chondroplasty, Cell-based Cartilage Resurfacing, Osteochondral Transplant, Meniscus Transplants, Other Procedures) Market by Application (Knee, Hips, Other Applications) Market by End-user (Ambulatory Surgical Centers, Hospitals & Specialty Clinics, Academic & Research Institutes) by Geography

Request free sample

The global cartilage degeneration market is anticipated to register a CAGR of 4.64% over the forecasted years and is expected to generate revenue of $11551.2 million by 2028. While the base year considered for the market study is 2020, the forecast period is from 2021 to 2028.

Cartilage is a smooth, connective tissue that cushions the meeting area of joints and bone. The degeneration of cartilage can cause chronic inflammation in the joints. Some of the risk factors for cartilage denegation include weight, aging, accidental injury, sports injuries, or trauma to joints such as knees or hips.Cartilage Degeneration Market

To learn more about this report, request a free sample copy

Key factors propelling the global cartilage degeneration market growth:

  • Sports injuries damaging cartilage and ligaments
    • The rising number of sports injuries among athletes and players is anticipated to drive the growth of the cartilage degeneration market during the forecast period.
    • As per a study published by Stanford Children’s Health in 2020, an estimated 30 million teenagers and children participated in sports annually in the United States.
  • Degeneration of cartilage due to obesity
  • Bone and joint-related diseases in the geriatric population

Major growth restraining factors:

  • High cost of cartilage repair therapies
    • According to the data published by Arthritis Foundation 2020, single-knee allograft costs around US$14,000 in the United States.
    • Hence, the high cost of cartilage repair therapies is projected to restrain the growth of the market.
  • Lack of favorable regulatory environment

The report scope of the global cartilage degeneration market includes segmentation analysis based on procedure, application, and end-user. One of these segments is further classified to provide a detailed analysis of the studied market.

Market by Application:

  • Knee
    • The knee segment is set to lead the application category. Besides, the segment holds the highest share in terms of the total number of bone-related surgeries.
    • The rising number of knee injuries and obesity are likely to drive the segment’s growth.
    • Furthermore, increasing participation in sports and aging are among the top factors bolstering the prevalence of knee injuries.
  • Hips
  • Other Applications

Geographically, the global cartilage degeneration market has been segmented based on four major regions, which includes:

  • North America: The United States and Canada
    • North America dominated the global market in 2020.
    • The United States captured a significant share within the region’s cartilage degeneration market.
    • Obesity elevates the risk of several complications such as degenerative and inflammatory conditions, including osteoarthritis as well as joint pain and joint degeneration. Therefore, this factor plays a vital role in driving the North America market growth during the forecast period.
  • Europe: The United Kingdom, Germany, Italy, France, Belgium, Russia, Poland, and Rest of Europe
  • Asia-Pacific: Japan, India, China, South Korea, Australia & New Zealand, Thailand, Indonesia, Singapore, and Rest of Asia-Pacific
    • The Asia-Pacific is set to grow with the highest CAGR during the forecasted period.
    • China is the largest market for cartilage degeneration across the Asia-Pacific.
    • The region’s market growth is primarily attributed to the increasing adoption of advanced technology, rising developments by the market players, and favorable regulatory policies.
    • Besides, the growing geriatric population is an important factor responsible for the growth of the cartilage degeneration market in the Asia-Pacific.
  • Rest of World: Latin America, the Middle East & Africa

The major market players in the global cartilage degeneration market:

  • Arthrex Inc
  • Depuy Synthes Companies
  • Smith & Nephew PLC
  • Stryker Corporation
  • Zimmer Biomet Holdings
  • Others

Key strategies adopted by some of these companies:

In January 2021, Stryker announced the acquisition of OrthoSensor Inc, a leader in the digital development of sensor technology and musculoskeletal care for total joint replacement.

Key findings of the global cartilage degeneration market:

  • Product approvals and developments offer lucrative opportunities for the global market’s growth.
  • The prominence of regenerative medicines serves as a key market trend within the global cartilage degeneration market

 

Frequently Asked Questions (FAQs):

  • How is the prevalence of obesity likely to enhance the global cartilage degeneration market?

A: The immense pervasiveness of obesity is likely to accelerate due to unhealthy regimes such as consumption of sedentary lifestyle, genetic conditions, junk food, and deprivation of mental health. Obesity causes osteoarthritis leading to cartilage degeneration by elevating the mechanical stress on the cartilage, thereby boosting the global cartilage degeneration market.

  • Why is the rise in the aging population projected to drive the global cartilage degeneration market?

A: The rising aging population leads to several bone- and joint-related diseases such as osteoarthritis, rheumatoid arthritis, tendinitis. Moreover, the risk of arthritis increases with age. Hence, the incidence of the aging population is projected to augment the global cartilage degeneration market.

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


    1. RESEARCH SCOPE & METHODOLOGY
      • STUDY OBJECTIVES
      • SCOPE OF STUDY
      • METHODOLOGY
      • ASSUMPTIONS & LIMITATIONS
    2. EXECUTIVE SUMMARY
      • MARKET SIZE & ESTIMATES
      • MARKET OVERVIEW
    3. MARKET DYNAMICS
      • KEY DRIVERS
        • SPORTS INJURIES DAMAGING CARTILAGE AND LIGAMENTS
        • DEGENERATION OF CARTILAGE DUE TO OBESITY
        • BONE AND JOINT-RELATED DISEASES IN THE GERIATRIC POPULATION
      • KEY RESTRAINTS
        • HIGH COST OF CARTILAGE REPAIR THERAPIES
        • LACK OF FAVORABLE REGULATORY ENVIRONMENT
    1. KEY ANALYTICS
      • IMPACT OF COVID-19 ON CARTILAGE DEGENERATION MARKET
      • KEY MARKET TRENDS
      • PORTER’S FIVE FORCES ANALYSIS
        • THREAT OF NEW ENTRY
        • THREAT OF SUBSTITUTION
        • BUYERS POWER
        • SUPPLIERS POWER
        • COMPETITIVE RIVALRY
      • OPPORTUNITY MATRIX
      • VENDOR LANDSCAPE
    2. MARKET BY PROCEDURE
      • JOINT REPLACEMENT
      • CHONDROPLASTY
      • CELL-BASED CARTILAGE RESURFACING
      • OSTEOCHONDRAL TRANSPLANT
      • MENISCUS TRANSPLANTS
      • OTHER PROCEDURES
    3. MARKET BY APPLICATION
      • KNEE
      • HIPS
      • OTHER APPLICATIONS
    4. MARKET BY END-USER
      • AMBULATORY SURGICAL CENTERS
      • HOSPITALS & SPECIALTY CLINICS
      • ACADEMIC & RESEARCH INSTITUTES
    5. GEOGRAPHICAL ANALYSIS
      • NORTH AMERICA
        • MARKET SIZE & ESTIMATES
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • COUNTRY ANALYSIS
          • UNITED STATES
          • CANADA
      • EUROPE
        • MARKET SIZE & ESTIMATES
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • COUNTRY ANALYSIS
          • GERMANY
          • UNITED KINGDOM
          • FRANCE
          • ITALY
          • RUSSIA
          • POLAND
          • BELGIUM
          • REST OF EUROPE
      • ASIA-PACIFIC
        • MARKET SIZE & ESTIMATES
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • COUNTRY ANALYSIS
          • CHINA
          • JAPAN
          • AUSTRALIA & NEW ZEALAND
          • INDIA
          • SOUTH KOREA
          • THAILAND
          • SINGAPORE
          • INDONESIA
          • REST OF ASIA-PACIFIC
      • REST OF WORLD
        • MARKET SIZE & ESTIMATES
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • REGIONAL ANALYSIS
          • LATIN AMERICA
          • MIDDLE EAST & AFRICA
    1. COMPETITIVE LANDSCAPE
      • KEY STRATEGIC DEVELOPMENTS
        • MERGERS & ACQUISITIONS
        • PRODUCT LAUNCHES & DEVELOPMENTS
        • PARTNERSHIPS & AGREEMENTS
        • BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES
      • COMPANY PROFILES
        • ANIKA THERAPEUTICS INC
        • ARTHREX INC
        • B BRAUN MELSUNGEN AG
        • BIOTISSUE SA
        • CARTIHEAL INC
        • CONMED CORPORATION
        • DEPUY SYNTHES COMPANIES
        • OSIRIS THERAPEUTICS INC
        • RTI SURGICAL INC
        • SMITH & NEPHEW PLC
        • STRYKER CORPORATION
        • VERICEL CORPORATION
        • ZIMMER BIOMET HOLDINGS

    LIST OF TABLES  

    TABLE 1: MARKET SNAPSHOT – CARTILAGE DEGENERATION

    TABLE 2: NUMBER OF PERSONS AGED 65 YEARS OR OVER, BY GEOGRAPHIC REGION, 2019 AND 2050

    TABLE 3: GLOBAL CARTILAGE DEGENERATION MARKET, BY PROCEDURE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 4: GLOBAL CARTILAGE DEGENERATION MARKET, BY PROCEDURE, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 5: GLOBAL JOINT REPLACEMENT MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 6: GLOBAL JOINT REPLACEMENT MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 7: GLOBAL CHONDROPLASTY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 8: GLOBAL CHONDROPLASTY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 9: GLOBAL CELL-BASED CARTILAGE RESURFACING MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 10: GLOBAL CELL-BASED CARTILAGE RESURFACING MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 11: GLOBAL OSTEOCHONDRAL TRANSPLANT MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 12: GLOBAL OSTEOCHONDRAL TRANSPLANT MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 13: GLOBAL MENISCUS TRANSPLANTS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 14: GLOBAL MENISCUS TRANSPLANTS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 15: GLOBAL OTHER PROCEDURES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 16: GLOBAL OTHER PROCEDURES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 17: GLOBAL CARTILAGE DEGENERATION MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 18: GLOBAL CARTILAGE DEGENERATION MARKET, BY APPLICATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 19: GLOBAL KNEE MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 20: GLOBAL KNEE MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 21: GLOBAL HIPS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 22: GLOBAL HIPS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 23: GLOBAL OTHER APPLICATIONS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 24: GLOBAL OTHER APPLICATIONS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 25: GLOBAL CARTILAGE DEGENERATION MARKET, BY END-USER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 26: GLOBAL CARTILAGE DEGENERATION MARKET, BY END-USER, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 27: GLOBAL AMBULATORY SURGICAL CENTERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 28: GLOBAL AMBULATORY SURGICAL CENTERS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 29: GLOBAL HOSPITALS & SPECIALTY CLINICS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 30: GLOBAL HOSPITALS & SPECIALTY CLINICS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 31: GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 32: GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 33: GLOBAL CARTILAGE DEGENERATION MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 34: GLOBAL CARTILAGE DEGENERATION MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 35: NORTH AMERICA CARTILAGE DEGENERATION MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 36: NORTH AMERICA CARTILAGE DEGENERATION MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 37: LEADING PLAYERS OPERATING IN THE NORTH AMERICA CARTILAGE DEGENERATION MARKET

    TABLE 38: EUROPE CARTILAGE DEGENERATION MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 39: EUROPE CARTILAGE DEGENERATION MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 40: LEADING PLAYERS OPERATING IN EUROPE CARTILAGE DEGENERATION MARKET

    TABLE 41: ASIA-PACIFIC CARTILAGE DEGENERATION MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 42: ASIA-PACIFIC CARTILAGE DEGENERATION MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 43: LEADING PLAYERS OPERATING IN ASIA-PACIFIC CARTILAGE DEGENERATION MARKET

    TABLE 44: REST OF WORLD CARTILAGE DEGENERATION MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 45: REST OF WORLD CARTILAGE DEGENERATION MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 46: LEADING PLAYERS OPERATING IN REST OF WORLD CARTILAGE DEGENERATION MARKET

    TABLE 47: LIST OF MERGERS & ACQUISITIONS

    TABLE 48: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

    TABLE 49: LIST OF PARTNERSHIPS & AGREEMENTS

    TABLE 50: LIST OF BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES

    LIST OF FIGURES 

    FIGURE 1: KEY MARKET TRENDS

    FIGURE 2: PORTER’S FIVE FORCES ANALYSIS

    FIGURE 3: OPPORTUNITY MATRIX

    FIGURE 4: VENDOR LANDSCAPE

    FIGURE 5: GLOBAL CARTILAGE DEGENERATION MARKET, BY PROCEDURE, IN 2020

    FIGURE 6: GLOBAL CARTILAGE DEGENERATION MARKET, BY JOINT REPLACEMENT, 2021-2028 (IN $ MILLION)

    FIGURE 7: GLOBAL CARTILAGE DEGENERATION MARKET, BY CHONDROPLASTY, 2021-2028 (IN $ MILLION)

    FIGURE 8: GLOBAL CARTILAGE DEGENERATION MARKET, BY CELL-BASED CARTILAGE RESURFACING, 2021-2028 (IN $ MILLION)

    FIGURE 9: GLOBAL CARTILAGE DEGENERATION MARKET, BY OSTEOCHONDRAL TRANSPLANT, 2021-2028 (IN $ MILLION)

    FIGURE 10: GLOBAL CARTILAGE DEGENERATION MARKET, BY MENISCUS TRANSPLANTS, 2021-2028 (IN $ MILLION)

    FIGURE 11: GLOBAL CARTILAGE DEGENERATION MARKET, BY OTHER PROCEDURES, 2021-2028 (IN $ MILLION)

    FIGURE 12: GLOBAL CARTILAGE DEGENERATION MARKET, BY APPLICATION, IN 2020

    FIGURE 13: GLOBAL CARTILAGE DEGENERATION MARKET, BY KNEE, 2021-2028 (IN $ MILLION)

    FIGURE 14: GLOBAL CARTILAGE DEGENERATION MARKET, BY HIPS, 2021-2028 (IN $ MILLION)

    FIGURE 15: GLOBAL CARTILAGE DEGENERATION MARKET, BY OTHER APPLICATIONS, 2021-2028 (IN $ MILLION)

    FIGURE 16: GLOBAL CARTILAGE DEGENERATION MARKET, BY END-USER, IN 2020

    FIGURE 17: GLOBAL CARTILAGE DEGENERATION MARKET, BY AMBULATORY SURGICAL CENTERS, 2021-2028 (IN $ MILLION)

    FIGURE 18: GLOBAL CARTILAGE DEGENERATION MARKET, BY HOSPITALS & SPECIALTY CLINICS, 2021-2028 (IN $ MILLION)

    FIGURE 19: GLOBAL CARTILAGE DEGENERATION MARKET, BY ACADEMIC & RESEARCH INSTITUTES, 2021-2028 (IN $ MILLION)

    FIGURE 20: NORTH AMERICA CARTILAGE DEGENERATION MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)

    FIGURE 21: UNITED STATES CARTILAGE DEGENERATION MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 22: CANADA CARTILAGE DEGENERATION MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 23: EUROPE CARTILAGE DEGENERATION MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)

    FIGURE 24: GERMANY CARTILAGE DEGENERATION MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 25: UNITED KINGDOM CARTILAGE DEGENERATION MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 26: FRANCE CARTILAGE DEGENERATION MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 27: ITALY CARTILAGE DEGENERATION MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 28: RUSSIA CARTILAGE DEGENERATION MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 29: POLAND CARTILAGE DEGENERATION MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 30: BELGIUM CARTILAGE DEGENERATION MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 31: REST OF EUROPE CARTILAGE DEGENERATION MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 32: ASIA-PACIFIC CARTILAGE DEGENERATION MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)

    FIGURE 33: CHINA CARTILAGE DEGENERATION MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 34: JAPAN CARTILAGE DEGENERATION MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 35: AUSTRALIA & NEW ZEALAND CARTILAGE DEGENERATION MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 36: INDIA CARTILAGE DEGENERATION MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 37: SOUTH KOREA CARTILAGE DEGENERATION MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 38: THAILAND CARTILAGE DEGENERATION MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 39: SINGAPORE CARTILAGE DEGENERATION MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 40: INDONESIA CARTILAGE DEGENERATION MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 41: REST OF ASIA-PACIFIC CARTILAGE DEGENERATION MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 42: REST OF WORLD CARTILAGE DEGENERATION MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)

    FIGURE 43: LATIN AMERICA CARTILAGE DEGENERATION MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 44: MIDDLE EAST & AFRICA CARTILAGE DEGENERATION MARKET, 2021-2028 (IN $ MILLION)

    1. MARKET BY PROCEDURE
      • JOINT REPLACEMENT
      • CHONDROPLASTY
      • CELL-BASED CARTILAGE RESURFACING
      • OSTEOCHONDRAL TRANSPLANT
      • MENISCUS TRANSPLANTS
      • OTHER PROCEDURES
    2. MARKET BY APPLICATION
      • KNEE
      • HIPS
      • OTHER APPLICATIONS
    3. MARKET BY END-USER
      • AMBULATORY SURGICAL CENTERS
      • HOSPITALS & SPECIALTY CLINICS
      • ACADEMIC & RESEARCH INSTITUTES
    4. GEOGRAPHICAL ANALYSIS
      • NORTH AMERICA
        • MARKET SIZE & ESTIMATES
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • COUNTRY ANALYSIS
          • UNITED STATES
          • CANADA
      • EUROPE
        • MARKET SIZE & ESTIMATES
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • COUNTRY ANALYSIS
          • GERMANY
          • UNITED KINGDOM
          • FRANCE
          • ITALY
          • RUSSIA
          • POLAND
          • BELGIUM
          • REST OF EUROPE
      • ASIA-PACIFIC
        • MARKET SIZE & ESTIMATES
        • KEY GROWTH ENABLER
        • KEY CHALLENGES
        • KEY PLAYERS
        • COUNTRY ANALYSIS
          • CHINA
          • JAPAN
          • AUSTRALIA & NEW ZEALAND
          • INDIA
          • SOUTH KOREA
          • THAILAND
          • SINGAPORE
          • INDONESIA
          • REST OF ASIA-PACIFIC
      • REST OF WORLD
        • MARKET SIZE & ESTIMATES
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • REGIONAL ANALYSIS
          • LATIN AMERICA
          • MIDDLE EAST & AFRICA

    To request a free sample copy of this report, please complete the form below :

    We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


      Choose License Type